Oliver McFarlane syndrome: two new cases and a review of the literature

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Oliver McFarlane syndrome : two new cases and a review of the literature. / Lisbjerg, Kristian; Andersen, Mette K.G.; Bertelsen, Mette; Brost, Agnes G.; Buchvald, Frederik F.; Jensen, Rikke B.; Bisgaard, Anne Marie; Rosenberg, Thomas; Tümer, Zeynep; Kessel, Line.

In: Ophthalmic Genetics, Vol. 42, No. 4, 2021, p. 464-473.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Lisbjerg, K, Andersen, MKG, Bertelsen, M, Brost, AG, Buchvald, FF, Jensen, RB, Bisgaard, AM, Rosenberg, T, Tümer, Z & Kessel, L 2021, 'Oliver McFarlane syndrome: two new cases and a review of the literature', Ophthalmic Genetics, vol. 42, no. 4, pp. 464-473. https://doi.org/10.1080/13816810.2021.1904419

APA

Lisbjerg, K., Andersen, M. K. G., Bertelsen, M., Brost, A. G., Buchvald, F. F., Jensen, R. B., Bisgaard, A. M., Rosenberg, T., Tümer, Z., & Kessel, L. (2021). Oliver McFarlane syndrome: two new cases and a review of the literature. Ophthalmic Genetics, 42(4), 464-473. https://doi.org/10.1080/13816810.2021.1904419

Vancouver

Lisbjerg K, Andersen MKG, Bertelsen M, Brost AG, Buchvald FF, Jensen RB et al. Oliver McFarlane syndrome: two new cases and a review of the literature. Ophthalmic Genetics. 2021;42(4):464-473. https://doi.org/10.1080/13816810.2021.1904419

Author

Lisbjerg, Kristian ; Andersen, Mette K.G. ; Bertelsen, Mette ; Brost, Agnes G. ; Buchvald, Frederik F. ; Jensen, Rikke B. ; Bisgaard, Anne Marie ; Rosenberg, Thomas ; Tümer, Zeynep ; Kessel, Line. / Oliver McFarlane syndrome : two new cases and a review of the literature. In: Ophthalmic Genetics. 2021 ; Vol. 42, No. 4. pp. 464-473.

Bibtex

@article{f8c8f5247cbd42c3b358bc5c81cf2f39,
title = "Oliver McFarlane syndrome: two new cases and a review of the literature",
abstract = "Background: Oliver McFarlane syndrome is a rare syndrome. Clinical presentations include trichomegaly, chorioretinal degeneration, pituitary hormone deficits, and neurological manifestations. Genetic analysis has recently placed this syndrome within the group of PNPLA6-related disorders. Here, we describe two new individuals and review the previously published cases. Materials and methods: Clinical investigations were carried out in accordance with local guidelines and clinical information was retrieved from medical records. Genetic studies were carried out using next-generation sequencing based clinical exome sequencing. A PubMed literature search was performed with a review of the published clinical cases of Oliver McFarlane syndrome. Results: Our first individual was a 36-year-old woman with 32 years of follow up and our second individual was a 3-year-old boy. Both individuals were born preterm and presented with prolonged neonatal respiratory distress, trichomegaly, early growth retardation, retinopathy and sparse depigmented hair. So far, none of our cases have demonstrated cognitive impairment or progressive neurological symptoms, but the child revealed persistent abnormal lung structure. Both individuals were compound heterozygous for pathogenic PNPLA6 variants, one of which was novel. We found other 31 clinically documented published cases. Conclusions: Our two new unrelated cases of Oliver McFarlane Syndrome demonstrate early ophthalmological and systemic findings of this rare syndrome and the progressive nature of the retinopathy with a long follow-up. PNPLA6-related disorders are a phenotypically highly heterogenous group where alterations in the phosphatidylcholine metabolism can lead to manifestations in different tissues with no clear genotype-phenotype correlation.",
keywords = "lung architecture, Oliver McFarlane, PNPLA6, retinal degeneration, subretinal deposits, trichomegaly",
author = "Kristian Lisbjerg and Andersen, {Mette K.G.} and Mette Bertelsen and Brost, {Agnes G.} and Buchvald, {Frederik F.} and Jensen, {Rikke B.} and Bisgaard, {Anne Marie} and Thomas Rosenberg and Zeynep T{\"u}mer and Line Kessel",
year = "2021",
doi = "10.1080/13816810.2021.1904419",
language = "English",
volume = "42",
pages = "464--473",
journal = "Ophthalmic Genetics",
issn = "1381-6810",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Oliver McFarlane syndrome

T2 - two new cases and a review of the literature

AU - Lisbjerg, Kristian

AU - Andersen, Mette K.G.

AU - Bertelsen, Mette

AU - Brost, Agnes G.

AU - Buchvald, Frederik F.

AU - Jensen, Rikke B.

AU - Bisgaard, Anne Marie

AU - Rosenberg, Thomas

AU - Tümer, Zeynep

AU - Kessel, Line

PY - 2021

Y1 - 2021

N2 - Background: Oliver McFarlane syndrome is a rare syndrome. Clinical presentations include trichomegaly, chorioretinal degeneration, pituitary hormone deficits, and neurological manifestations. Genetic analysis has recently placed this syndrome within the group of PNPLA6-related disorders. Here, we describe two new individuals and review the previously published cases. Materials and methods: Clinical investigations were carried out in accordance with local guidelines and clinical information was retrieved from medical records. Genetic studies were carried out using next-generation sequencing based clinical exome sequencing. A PubMed literature search was performed with a review of the published clinical cases of Oliver McFarlane syndrome. Results: Our first individual was a 36-year-old woman with 32 years of follow up and our second individual was a 3-year-old boy. Both individuals were born preterm and presented with prolonged neonatal respiratory distress, trichomegaly, early growth retardation, retinopathy and sparse depigmented hair. So far, none of our cases have demonstrated cognitive impairment or progressive neurological symptoms, but the child revealed persistent abnormal lung structure. Both individuals were compound heterozygous for pathogenic PNPLA6 variants, one of which was novel. We found other 31 clinically documented published cases. Conclusions: Our two new unrelated cases of Oliver McFarlane Syndrome demonstrate early ophthalmological and systemic findings of this rare syndrome and the progressive nature of the retinopathy with a long follow-up. PNPLA6-related disorders are a phenotypically highly heterogenous group where alterations in the phosphatidylcholine metabolism can lead to manifestations in different tissues with no clear genotype-phenotype correlation.

AB - Background: Oliver McFarlane syndrome is a rare syndrome. Clinical presentations include trichomegaly, chorioretinal degeneration, pituitary hormone deficits, and neurological manifestations. Genetic analysis has recently placed this syndrome within the group of PNPLA6-related disorders. Here, we describe two new individuals and review the previously published cases. Materials and methods: Clinical investigations were carried out in accordance with local guidelines and clinical information was retrieved from medical records. Genetic studies were carried out using next-generation sequencing based clinical exome sequencing. A PubMed literature search was performed with a review of the published clinical cases of Oliver McFarlane syndrome. Results: Our first individual was a 36-year-old woman with 32 years of follow up and our second individual was a 3-year-old boy. Both individuals were born preterm and presented with prolonged neonatal respiratory distress, trichomegaly, early growth retardation, retinopathy and sparse depigmented hair. So far, none of our cases have demonstrated cognitive impairment or progressive neurological symptoms, but the child revealed persistent abnormal lung structure. Both individuals were compound heterozygous for pathogenic PNPLA6 variants, one of which was novel. We found other 31 clinically documented published cases. Conclusions: Our two new unrelated cases of Oliver McFarlane Syndrome demonstrate early ophthalmological and systemic findings of this rare syndrome and the progressive nature of the retinopathy with a long follow-up. PNPLA6-related disorders are a phenotypically highly heterogenous group where alterations in the phosphatidylcholine metabolism can lead to manifestations in different tissues with no clear genotype-phenotype correlation.

KW - lung architecture

KW - Oliver McFarlane

KW - PNPLA6

KW - retinal degeneration

KW - subretinal deposits

KW - trichomegaly

U2 - 10.1080/13816810.2021.1904419

DO - 10.1080/13816810.2021.1904419

M3 - Journal article

C2 - 33818269

AN - SCOPUS:85103645300

VL - 42

SP - 464

EP - 473

JO - Ophthalmic Genetics

JF - Ophthalmic Genetics

SN - 1381-6810

IS - 4

ER -

ID: 259884122